462 results on '"Mckoy, June M."'
Search Results
2. Increasing physical activity among older adults with gynecologic cancers: a qualitative study
3. Common Infections
4. Perspectives on the Cost and Value of Stem Cell and Emerging Therapies, Comprehensive Hematology and Stem Cell Research
5. Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos
6. Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
7. Cancer Drug Toxicity: Moving from Patient to Survivor
8. Biosimilars: Are They Really Safe?
9. Pharmacovigilance of Alternative Medications in the Cancer Setting
10. Cancer Comorbidity: Implications for Drug Safety
11. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)
12. Ambulatory and Outpatient Care
13. Engaging disparities in prostate cancer: Piloting an interactive, virtual workshop to educate providers on shared decision-making for underserved populations
14. Sepsis in Older Adults
15. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update
16. Ambulatory and Outpatient Care
17. Pharmacovigilance of Alternative Medications in the Cancer Setting
18. Biosimilars: Are They Really Safe?
19. Cancer Drug Toxicity: Moving from Patient to Survivor
20. Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
21. Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos
22. Cancer Comorbidity: Implications for Drug Safety
23. Mistreatment and Wellness Among International Medical Graduates in US General Surgical Residency
24. Integrating Geriatric Assessment Measures into National Cancer Institute Clinical Trials
25. Does Reimbursement Affect Physicians’ Decision Making? Examples from the Use of Recombinent Erythropoietin
26. Comparison of the Sensitivity of a Pre-MRI Questionnaire and Point of Care eGFR Testing for Detection of Impaired Renal Function
27. Amiodarone-associated Optic Neuropathy: A Critical Review
28. Social Justice and Equity: Why Older Adults With Cancer Belong—A Life Course Perspective
29. Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians
30. Improving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network
31. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report
32. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)
33. Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
34. NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
35. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw
36. Adverse Drug Interactions: Moving from Perception to Action
37. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence from the Patient Navigation Research Program
38. Hepatotoxicity Associated with Long-versus Short-Course HIV-Prophylactic Nevirapine Use: A Systematic Review and Meta-Analysis from the Research on Adverse Drug events And Reports (RADAR) Project
39. Caveat patiens — ethical dilemmas in decision -making
40. Older Patients’ Perceptions of Medication Importance and Worth: An Exploratory Pilot Study
41. Health Equity for Older Adults With Cancer
42. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
43. Systematic Review of Piperacillin-Induced Neutropenia
44. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019):A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)
45. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project
46. Granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer: The 40% rule revisited
47. The research on Adverse Drug Events and Reports (RADAR) project
48. Pure red-cell aplasia and epoetin therapy
49. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)
50. Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts: A Systematic Review from the Research on Adverse Drug Events And Reports (RADAR) Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.